Survival analysis has indicated that a high lncRNA DRAIC expression was associated with a remarkably favorable overall survival and progression-free survival of lower-grade glioma patients who had been submitted to radiotherapy (23). The gene discussed is DRAIC; the disease is central nervous system cancer.